
    
      The study wants to define the maximum tolerated dose (MTD) of a conformal short course
      radiation treatment delivered in twice daily fractions and 2 consecutive days, and the
      feasibility of this fractionation in term of safety and efficacy for symptomatic palliation
      of complicated bone metastases.
    
  